BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

568 related articles for article (PubMed ID: 32948090)

  • 1. Extracellular Vesicles as Nanotherapeutics for Parkinson's Disease.
    Leggio L; Paternò G; Vivarelli S; L'Episcopo F; Tirolo C; Raciti G; Pappalardo F; Giachino C; Caniglia S; Serapide MF; Marchetti B; Iraci N
    Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32948090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glia-Derived Extracellular Vesicles in Parkinson's Disease.
    Marchetti B; Leggio L; L'Episcopo F; Vivarelli S; Tirolo C; Paternò G; Giachino C; Caniglia S; Serapide MF; Iraci N
    J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32575923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular Vesicles in Alzheimer's and Parkinson's Disease: Small Entities with Large Consequences.
    Vandendriessche C; Bruggeman A; Van Cauwenberghe C; Vandenbroucke RE
    Cells; 2020 Nov; 9(11):. PubMed ID: 33203181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular Vesicles and Neurodegenerative Diseases.
    Hill AF
    J Neurosci; 2019 Nov; 39(47):9269-9273. PubMed ID: 31748282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers for parkinsonian disorders in CNS-originating EVs: promise and challenges.
    Dutta S; Hornung S; Taha HB; Bitan G
    Acta Neuropathol; 2023 May; 145(5):515-540. PubMed ID: 37012443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential of extracellular vesicles in the Parkinson's disease - Pathological mediators and biomarkers.
    Zhao Y; Yang G
    Neurochem Int; 2021 Mar; 144():104974. PubMed ID: 33485881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Potential Roles of Extracellular Vesicles as Biomarkers for Parkinson's Disease: A Systematic Review.
    Valencia J; Ferreira M; Merino-Torres JF; Marcilla A; Soriano JM
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Propagation of Parkinson's disease by extracellular vesicle production and secretion.
    Shippey LE; Campbell SG; Hill AF; Smith DP
    Biochem Soc Trans; 2022 Oct; 50(5):1303-1314. PubMed ID: 36111783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular Vesicles in the Treatment of Parkinson's Disease: A Review.
    Yang X; Ma Y; Xie H; Dong S; Rao G; Yang Z; Zhang J; Wu Q
    Curr Med Chem; 2021; 28(31):6375-6394. PubMed ID: 33441061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular vesicles, from the pathogenesis to the therapy of neurodegenerative diseases.
    Xia X; Wang Y; Zheng JC
    Transl Neurodegener; 2022 Dec; 11(1):53. PubMed ID: 36510311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular Vesicles for the Diagnosis and Treatment of Parkinson's Disease.
    Upadhya R; Shetty AK
    Aging Dis; 2021 Sep; 12(6):1438-1450. PubMed ID: 34527420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein Deimination Signatures in Plasma and Plasma-EVs and Protein Deimination in the Brain Vasculature in a Rat Model of Pre-Motor Parkinson's Disease.
    Sancandi M; Uysal-Onganer P; Kraev I; Mercer A; Lange S
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32326590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transmission of α-synuclein-containing erythrocyte-derived extracellular vesicles across the blood-brain barrier via adsorptive mediated transcytosis: another mechanism for initiation and progression of Parkinson's disease?
    Matsumoto J; Stewart T; Sheng L; Li N; Bullock K; Song N; Shi M; Banks WA; Zhang J
    Acta Neuropathol Commun; 2017 Sep; 5(1):71. PubMed ID: 28903781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic potential of extracellular vesicles in neurodegenerative disorders.
    Roudi S; Rädler JA; El Andaloussi S
    Handb Clin Neurol; 2023; 193():243-266. PubMed ID: 36803815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interplay between aging-associated loss of protein homeostasis and extracellular vesicles in neurodegeneration.
    Guix FX
    J Neurosci Res; 2020 Feb; 98(2):262-283. PubMed ID: 31549445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of extracellular vesicles in neurodegenerative diseases.
    Xiao Y; Wang SK; Zhang Y; Rostami A; Kenkare A; Casella G; Yuan ZQ; Li X
    Prog Neurobiol; 2021 Jun; 201():102022. PubMed ID: 33617919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intercellular transfer of pathogenic α-synuclein by extracellular vesicles is induced by the lipid peroxidation product 4-hydroxynonenal.
    Zhang S; Eitan E; Wu TY; Mattson MP
    Neurobiol Aging; 2018 Jan; 61():52-65. PubMed ID: 29035751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical implications of extracellular vesicles in neurodegenerative diseases.
    Vinaiphat A; Sze SK
    Expert Rev Mol Diagn; 2019 Sep; 19(9):813-824. PubMed ID: 31429341
    [No Abstract]   [Full Text] [Related]  

  • 19. Emerging roles of extracellular vesicles in neurodegenerative disorders.
    You Y; Ikezu T
    Neurobiol Dis; 2019 Oct; 130():104512. PubMed ID: 31229685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Transport Mechanism of Extracellular Vesicles at the Blood-Brain Barrier.
    Matsumoto J; Stewart T; Banks WA; Zhang J
    Curr Pharm Des; 2017; 23(40):6206-6214. PubMed ID: 28914201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.